Related Experiment Video

Updated: Aug 12, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Pharmacokinetics and renal function in preterm infants

J N van den Anker1

  • 1Department of Pediatrics, Erasmus University, Rotterdam, The Netherlands.

Acta Paediatrica (Oslo, Norway : 1992)
|December 1, 1996
PubMed

Insights

Advances in neonatal care improve preterm infant survival. However, optimizing drug therapy (pharmacotherapy) requires understanding how organ maturation affects drug processing and elimination in these vulnerable infants.

Area of Science:

  • Neonatal Medicine
  • Developmental Pharmacology
  • Clinical Pharmacokinetics

Background:

  • Improving survival rates in preterm infants necessitates advancements in pharmacotherapy.
  • Understanding drug pharmacokinetics in neonates is crucial for safe and effective treatment.
  • Developmental changes in organ systems significantly impact drug disposition.

Purpose of the Study:

  • To review the impact of maturational changes on renal function in preterm infants.
  • To analyze how these changes affect clinical pharmacokinetics.
  • To highlight the importance of understanding ontogeny in neonatal drug therapy.

Main Methods:

  • Literature review focusing on human developmental biology.
  • Analysis of studies on drug absorption, disposition, metabolism, and excretion in neonates.
  • Examination of the effects of renal function maturation on drug pharmacokinetics.

Main Results:

  • Organ system maturation and body composition changes significantly alter drug disposition in preterm infants.
  • Renal function maturation is a key factor influencing drug pharmacokinetics.
  • Drug-induced changes in renal function can further complicate pharmacotherapy.

Conclusions:

  • Effective pharmacotherapy in preterm infants demands a deep understanding of developmental physiology.
  • Maturation of renal function critically impacts drug efficacy and safety.
  • Further research is needed to optimize drug dosing and administration in this population.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Transdermal Measurement of Glomerular Filtration Rate in Mechanically Ventilated Piglets07:41

Transdermal Measurement of Glomerular Filtration Rate in Mechanically Ventilated Piglets

Published on: September 13, 2022

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...